With confirmed speakers.
Monday 01 June
NATURE AND NURTURE - IMPACT OF TRADITIONAL RISK FACTORS, ENVIRONMENT AND GENES
Global perspectives of cardiovascular disease, and impact of risk factors
Gregory Roth, Seattle, USA
Gregory Roth, Seattle, USA
Can polygenic scores reach clinical practice?
Anne Tybjerg Hansen, Copenhagen, Denmark
Anne Tybjerg Hansen, Copenhagen, Denmark
What is the environment doing to cardiovascular health?
Nicole Probst-Hensch, Basel, Switzerland
Nicole Probst-Hensch, Basel, Switzerland
Age, the unpreventable risk factor - targeting senescence
Jan Van Deursen, Rochester, USA
Jan Van Deursen, Rochester, USA
Tuesday 02 June
UNDERSTANDING BIOLOGY FOR CLINICAL APPLICATION
The lipoprotein(a) story - from risk factor to causality to clinical trials
Sotirios Tsimikas, La Jolla, USA
Sotirios Tsimikas, La Jolla, USA
Immune modulation in atherosclerosis
Ziad Mallat, Cambridge, UK
Ziad Mallat, Cambridge, UK
Prevention of cardiovascular diseases by glucose lowering drugs
Stefano del Prato, Pisa, Italy
Stefano del Prato, Pisa, Italy
Taming the gut microbiota
Stanley Hazen, Cleveland, USA
Stanley Hazen, Cleveland, USA
Wednesday 03 June
THE CHANGING LANDSCAPE IN ATHEROSCLEROTIC VASCULAR DISEASE - BRAVE NEW WORLD
Implementing systems biology to personalise medicine
Johan Björkegren, Stockholm, Sweden
Johan Björkegren, Stockholm, Sweden
AI in CVD & beyond
Jörg Menche, Vienna, Austria
Jörg Menche, Vienna, Austria
Personalised medicine in the elderly – how to avoid overtreatment
Heike Bischoff-Ferrari, Zurich, Switzerland
Heike Bischoff-Ferrari, Zurich, Switzerland
New therapeutic approaches
John Kastelein, Amsterdam, The Netherlands
John Kastelein, Amsterdam, The Netherlands
Wednesday 03 June
GUIDELINES SESSION
What is new in the guidelines, and what will it change for the clinician?
Lale Tokgözoglu, Ankara, Turkey
Lale Tokgözoglu, Ankara, Turkey
Future challenges in the guidelines
Alberico L. Catapano, Milan, Italy
Alberico L. Catapano, Milan, Italy
